1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 TOP-DOWN APPROACH
2.2 BOTTOM-UP APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL TRANSRADIAL ACCESS MARKET SNAPSHOT
3.2 GLOBAL TRANSRADIAL ACCESS MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL TRANSRADIAL ACCESS MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 HYPODERMIC NEEDLES
5.3 TRANSFUSION SETS
5.4 CATHETERS
5.5 GUIDEWIRES
5.6 OTHERS
6 GLOBAL TRANSRADIAL ACCESS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DIAGNOSTICS & TESTING
6.3 FLUID & NUTRITION ADMISTRATION
6.4 DRUGS ADMINSTRATION
6.5 OTHERS
7 GLOBAL TRANSRADIAL ACCESS MARKET, BY END- USER
7.1 OVERVIEW
7.2 CLINICS & AMBULATORY CARE CENTER
7.3 HOSPITALS
7.4 OTHERS
8 GLOBAL TRANSRADIAL ACCESS MARKET, BY GEOGRAPHY
8.1 NORTH AMERICA
8.1.1 MARKET DYNAMICS
8.1.1.1 DRIVERS
8.1.1.2 RESTRAINTS
8.1.1.3 OPPORTUNITY
8.1.2 U.S.
8.1.3 CANADA
8.1.4 MEXICO
8.2 EUROPE
8.2.1 MARKET DYNAMICS
8.2.1.1 DRIVERS
8.2.1.2 RESTRAINTS
8.2.1.3 OPPORTUNITY
8.2.2 U.K.
8.2.3 FRANCE
8.2.4 GERMANY
8.2.5 SPAIN
8.2.6 REST OF EUROPE
8.3 ASIA PACIFIC
8.3.1 MARKET DYNAMICS
8.3.1.1 DRIVERS
8.3.1.2 RESTRAINTS
8.3.1.3 OPPORTUNITY
8.3.2 INDIA
8.3.3 CHINA
8.3.4 JAPAN
8.3.5 REST OF ASIA PACIFIC
8.4 MIDDLE EAST AND AFRICA
8.4.1 MARKET DYNAMICS
8.4.1.1 DRIVERS
8.4.1.2 RESTRAINTS
8.4.1.3 OPPORTUNITY
8.4.2 SOUTH AFRICA
8.4.3 REST OF MIDDLE EAST AND AFRICA
8.5 LATIN AMERICA
8.5.1 MARKET DYNAMICS
8.5.1.1 DRIVERS
8.5.1.2 RESTRAINTS
8.5.1.3 OPPORTUNITY
8.5.2 BRAZIL
8.5.3 REST OF LATIN AMERICA
9 GLOBAL TRANSRADIAL ACCESS MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 AMECO MEDICAL
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 ANGIODYNAMICS INC.
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 BOSTON SCIENTIC CORPORATION
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 BECTON DICKINSON COMPANY
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 EDWARD LIFESCIENCES CORPORATION
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 MEDTRONIC
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 MERIT MEDICAL SYSTEMS
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
9.9 NIPRO MEDICAL CORPORATION
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS & SERVICES
9.9.3 KEY STRATEGY
9.9.4 RECENT DEVELOPMENTS
9.9.5 SWOT ANALYSIS
9.10 SMITHS MEDICAL
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS & SERVICES
9.10.3 KEY STRATEGY
9.10.4 RECENT DEVELOPMENTS
9.10.5 SWOT ANALYSIS